These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22570812)

  • 1. Effects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty.
    Lee SJ; Yang EM; Seo JY; Kim CJ
    Chonnam Med J; 2012 Apr; 48(1):27-31. PubMed ID: 22570812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.
    Anık A; Çatlı G; Abacı A; Böber E
    Indian J Endocrinol Metab; 2015; 19(2):267-71. PubMed ID: 25729690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.
    Yang WJ; Ko KH; Lee KH; Hwang IT; Oh YJ
    Ann Pediatr Endocrinol Metab; 2017 Mar; 22(1):49-54. PubMed ID: 28443259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty.
    Jang S; Kim SJ; Lee M; Lee HI; Kwon A; Suh J; Song K; Chae HW; Kim HS
    Ann Pediatr Endocrinol Metab; 2023 Dec; 28(4):283-288. PubMed ID: 36758971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty.
    Yang EH; Jo HY; Park SJ; Yoo HW; Choi SH; Kim HY; Park KH; Kim YM; Kwak MJ
    Ann Pediatr Endocrinol Metab; 2023 Mar; 28(1):49-53. PubMed ID: 37015776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
    Vuralli D; Ozon ZA; Gonc EN; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):99-105. PubMed ID: 31804960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty.
    Kim HR; Nam HK; Rhie YJ; Lee KH
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):259-265. PubMed ID: 29301187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFECTS OF THE GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY ON GROWTH AND BODY MASS INDEX IN GIRLS WITH IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY.
    Donbaloğlu Z; Bedel A; Çetiner EB; Singin B; Behram BA; Tuhan H; Parlak M
    Acta Endocrinol (Buchar); 2022; 18(2):181-186. PubMed ID: 36212259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment].
    Messaaoui A; Massa G; Tenoutasse S; Heinrichs C
    Rev Med Brux; 2005 Feb; 26(1):27-32. PubMed ID: 15816337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index evolution and ovarian function in adolescent girls who received GnRH agonist treatment for central precocious puberty or early and fast puberty.
    Buyukyilmaz G; Koca SB; Adiguzel KT; Gurbuz F; Boyraz M
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1044-1051. PubMed ID: 37735929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
    Lee HS; Yoon JS; Park KJ; Hwang JS
    PLoS One; 2018; 13(8):e0201906. PubMed ID: 30133462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
    Li P; Li Y; Yang CL
    Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty.
    Kim SW; Kim YB; Lee JE; Kim NR; Lee WK; Ku JK; Kim EJ; Jung SH; Chung WY
    Ann Pediatr Endocrinol Metab; 2017 Jun; 22(2):95-101. PubMed ID: 28690987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
    Corripio R; Soriano-Guillén L; Herrero FJ; Cañete R; Castro-Feijoó L; Escribano A; Espino R; Labarta JI; Argente J
    Horm Res Paediatr; 2016; 86(3):154-160. PubMed ID: 27529349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty.
    Yoon JW; Park HA; Lee J; Kim JH
    Korean J Pediatr; 2017 Dec; 60(12):395-402. PubMed ID: 29302264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
    Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.